Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Cansortium Reports Second Quarter 2021 Financial Results


      News provided by

      Cansortium Inc

      Aug 24, 2021, 16:05 ET

      Share this article

      Share this article


      Q2 Revenue up 24% YoY to $16.5 Million; Adjusted EBITDA up ~2x to $5.2 Million

      Management to Host Conference Call Tomorrow at 8:30 A.M. Eastern Time

      MIAMI, Aug. 24, 2021 /PRNewswire/ - Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated cannabis company operating under the Fluent™ brand, today announced financial results for the second quarter ended June 30, 2021, as well as recent operational highlights. Unless otherwise indicated, all results are presented in U.S. dollars.

      "We continued to drive growth and profitability in our key markets during the second quarter, as reflected by another month of record sales in May," said CEO Robert Beasley. "Our continued focus on providing differentiated, high-quality flower and wellness products has been well received by our patients. Additionally, we are now offering several boutique strains that have never been sold in the Florida market."

      Cansortium significantly improved its balance sheet during the quarter with debt and equity financings of nearly $90 million, which enabled the Company to cancel legacy debt and extend maturities to 2025, as well as redeem all outstanding convertible notes. Cansortium now has both the capital and flexibility needed to execute its expansion plans.

      Mr. Beasley continued, "Our core operations in Florida are performing well and our expansion plans are fully-funded. There have been minor supply chain and construction delays for several projects in Florida, which will delay the expected timing of our production ramp and push our schedule back by approximately two months. In addition, we have experienced delays in the Michigan market which, albeit a small market for us, will also impact our guidance for 2021 as we continue to hold product for sale to hedge against volatile pricing.

      "Overall, we continue to expect significant growth in 2021.  Our revised outlook for 2021 calls for $70-80 million of revenue with $18-26 million of adjusted EBITDA1, reflecting year-over-year growth of approximately 43% and 114%, respectively. We see upside to these numbers if the construction market opens up earlier than our current projections.

      _________________________________

      1 Adjusted EBITDA is a non-IFRS financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies. The Company calculates adjusted EBITDA from EBITDA plus (minus) unrealized loss (gain) on embedded derivatives, plus (minus) certain one-time non-operating expenses, as determined by management. A reconciliation from adjusted EBITDA to net loss is included in the accompanying financial schedules.

      "Other progress on various initiatives includes last week's opening of a new dispensary in Mechanicsburg, Pennsylvania, and securing our third Pennsylvania location in Annville, which we expect to open by the end of the year. In addition, we expect to open our 27th dispensary in Florida by the end of the third quarter and have identified four additional sites for continued growth in the first half of 2022."

      Q2 2021 Financial Highlights (vs. Q2 2020)

      • Revenue increased 24% to $16.5 million compared to $13.2 million.
      • Florida revenue increased 22% to $14.6 million compared to $12.0 million.
      • Adjusted gross profit2 increased 24% to $10.7 million or 65.1% of revenue, compared to $8.7 million or 65.5% of revenue.
      • Adjusted EBITDA approximately doubled to $5.2 million or 31.8% of revenue, compared to $2.6 million or 19.7% of revenue.
      • At June 30, 2021, the Company had approximately $26 million of cash and cash equivalents and $71 million of total debt, with approximately 264 million fully diluted shares outstanding (based on treasury stock method and share price on June 30, 2021).

      Recent Operational Highlights

      • Launched Sweetwater, a new line of premium cannabis whole flower.
      • Hired a new Head of Cultivation.
      • Appointed multiple new board members, including Mark Eckenrode, Alex Spiro, and the Company's new Executive Chairman of the Board, William Smith.
      • In July, the Company opened its 26th Florida dispensary in Deerfield Beach.
      • All convertible notes from the Company's capital structure were converted to shares during the second quarter. A total of approximately $18.0 million of debt was converted into common shares of the Company.
      • The Company sold approximately 2,600 lbs. of biomass from Michigan inventory in July.

      ____________________________________

      2 Adjusted gross profit is a non-IFRS financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies. The Company calculates adjusted gross profit from gross profit plus (minus) the changes in fair value of biological assets, as presented in the consolidated statement of operations.

      2021 Outlook
      The Company is revising its 2021 outlook for revenue to range between $70-$80 million, with adjusted EBITDA ranging between $18-$26 million. This compares to approximately $52 million of revenue and $10 million of adjusted EBITDA in 2020.

      In Florida, Cansortium continues to expect a total of 27 dispensaries to be operational by the end of 2021 and has identified four additional locations to be opened in 2022. In Michigan, the Company is holding 900 lbs. of flower prepared for sale. However, due to the pricing volatility, the Company is timing the sales cycle to realize optimal value.

      The Company's unaudited consolidated financial statements and accompanying notes, along with the Management Discussion and Analysis (MD&A), will be available under the Company's profile on SEDAR at www.sedar.com and are also accessible through the Investor Relations section of the Company's website at www.getfluent.com.

      Conference Call
      The Company will host a conference call and live audio webcast tomorrow at 8:30 a.m. Eastern time to discuss its financial results and operational highlights.

      Toll-free dial-in number: (800) 319-4610
      International dial-in number: (604) 638-5340
      Conference ID: 10016120
      Link: Cansortium Q2 2021 Earnings Call

      Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Elevate IR at (949) 200-4603.

      The conference call will also be available for replay via the News & Events section of the Company's investor relations website at https://investors.getfluent.com/.

      About Cansortium Inc.
      Cansortium is a vertically-integrated cannabis company with licenses and operations in Florida, Pennsylvania, Michigan and Texas. The Company operates under the Fluent™ brand and is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by Cansortium's unrelenting commitment to operational excellence in cultivation, production, distribution and retail. The Company is headquartered in Miami, Florida.

      Cansortium Inc.'s common shares trade on the CSE under the symbol "TIUM.U" and on the OTCQX Best Market under the symbol "CNTMF." For more information about the Company, please visit www.getfluent.com.

      Forward-Looking Information
      Certain information in this news release may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates, and projections regarding future events.

      Forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

      For further information: www.getfluent.com

      CANSORTIUM INC.







      CONSOLIDATED STATEMENT OF FINANCIAL POSITION





      (USD '000)
































      June 30,
      2021


      December 31,
      2020

      Assets







      Current assets







      Cash and cash equivalents




      $

      26,004


      $

      3,392

      Accounts receivable




      122


      148

      Inventory, net




      5,560


      5,006

      Biological assets




      2,495


      1,914

      Note receivable




      4,462


      3,859

      Prepaid income taxes




      1,598


      -

      Prepaid expenses and other current assets




      1,267


      1,365

      Total current assets




      41,508


      15,684








      Investment held for sale




      200


      200








      Property and equipment, net




      25,309


      19,517

      Intangible assets, net




      96,269


      97,035

      Right-of-use assets




      19,008


      19,094

      Deposit




      2,727


      1,050

      Goodwill




      1,526


      1,526

      Other assets




      486


      425

      Total assets




      $

      187,033


      $

      154,531








      Liabilities







      Current liabilities







      Accounts payable




      4,530


      4,808

      Accrued liabilities




      6,834


      7,614

      Income taxes payable




      -


      8,925

      Derivative liabilities




      -


      7,412

      Current portion of notes payable




      375


      38,583

      Lease obligations




      2,181


      1,894

      Total current liabilities




      13,920


      69,236





      -



      Notes payable, net of current portion and loan issuance costs




      53,410


      13,182

      Lease obligations, net of current portion




      20,889


      20,811

      Deferred income taxes




      24,430


      23,471

      Total liabilities




      112,649


      126,700








      Shareholders' equity







      Share capital




      196,588


      137,835

      Share-based compensation reserve




      5,717


      4,675

      Equity conversion feature




      11,044


      11,044

      Warrants




      30,148


      13,265

      Accumulated deficit




      (168,723)


      (138,609)

      Accumulated other comprehensive loss




      (390)


      (379)

      Total shareholders' equity 




      74,384


      27,831








      Total liabilities and shareholders' equity




      $

      187,033


      $

      154,531

      CANSORTIUM INC.











      STATEMENT OF OPERATIONS











      USD ('000)


























       For the three months
      ended June 30, 


       For the six months
      ended June 30, 










      2021


      2020


      2021


      2020












      Revenue, net of discounts




      $

      16,469


      $

      13,241


      $

      31,584


      $

      23,404

      Cost of goods sold




      5,745


      4,567


      11,152


      8,227

      Gross profit before fair value adjustments




      10,724


      8,674


      20,432


      15,177












      Realized fair value of increments on inventory sold




      (4,727)


      (4,953)


      (9,320)


      (12,515)

      Unrealized change in fair value of biological assets




      (1,224)


      7,572


      5,655


      19,682

      Gross profit




      4,773


      11,293


      16,767


      22,344












      Expenses











      General and administrative




      2,868


      3,064


      6,156


      6,202

      Share-based compensation




      285


      2,362


      3,517


      3,249

      Sales and marketing




      3,515


      3,481


      7,061


      6,602

      Depreciation and amortization




      1,547


      1,572


      3,078


      3,074

      Total expenses




      8,215


      10,479


      19,812


      19,127












      Loss from operations




      (3,442)


      814


      (3,045)


      3,217












      Other expense (income)











      Interest expense, net




      4,719


      3,798


      7,849


      7,557

      Change in fair market value of derivative liability




      (1,143)


      (828)


      (1,551)


      1,007

      Loss on debt settlement




      10,751


      -


      10,751


      -

      Private placement issuance expense




      6,640


      -


      6,640


      -

      Equity loss on investment in associate




      -


      31


      -


      215

      Loss on debt restructuring




      -


      -


      -


      8,065

      (Gain)/Loss on disposal of assets




      1


      (54)


      50


      (54)

      Other (income) expense 




      (18)


      (8)


      (131)


      7

      Total other expense (income)




      20,950


      2,939


      23,609


      16,797












      Loss before income taxes




      (24,392)


      (2,125)


      (26,654)


      (13,580)












      Income taxes




      594


      3,308


      3,431


      6,141












      Net loss




      (24,986)


      (5,433)


      (30,085)


      (19,721)












      (Gain)/Loss from discontinued operations




      33


      34


      31


      (342)












      Net loss after discontinued operations




      $

      (25,019)


      $

      (5,467)


      $

      (30,115)


      $

      (19,379)












      Other comprehensive loss:











      Foreign exchange translation gain (loss)




      (16)


      254


      (11)


      184












      Comprehensive loss




      $

      (25,035)


      $

      (5,213)


      $

      (30,126)


      $

      (19,195)












      Net loss per share











      Basic




      $

      (0.11)


      $

      (0.03)


      $

      (0.14)


      $

      (0.10)

      Diluted




      $

      (0.11)


      $

      (0.03)


      $

      (0.14)


      $

      (0.10)

      CANSORTIUM INC.



      STATEMENTS OF CASH FLOWS



      (USD '000)







       For the six months ended June 30, 


      2021

      2020

      Operating activities



      Net loss

      $

      (30,115)

      $

      (19,379)

      Adjustments to reconcile net loss to net cash used in operating activities:



      Unrealized gain on changes in fair value of biological assets

      (5,655)

      (19,682)

      Realized gain on changes in fair value of biological assets

      9,320

      12,515

      Share-based compensation

      3,517

      3,249

      Depreciation and amortization

      4,675

      4,059

      Discontinued operations

      31

      (342)

      Accretion of convertible debentures

      2,242

      3,834

      Interest on lease liabilities

      1,257

      1,987

      Change in fair market value of derivative

      (1,551)

      1,007

      Loss on investment in associate

      -

      215

      Loss on debt restructuring

      -

      8,065

      Loss on debt settlement

      10,751

      -

      (Gain)/Loss on disposal of assets

      50

      (54)

      Deferred tax expense

      959

      1,862

      Changes in operating assets and liabilities:



      Accounts receivable

      26

      11

      Inventory

      (554)

      (5,401)

      Biological assets

      (4,246)

      5,265

      Prepaid expenses and other current assets

      1,875

      (646)

      Right-of-use assets

      (1,280)

      (728)

      Right-of-use liabilties

      1,262

      -

      Other assets

      (61)

      (84)

      Accounts payable

      (278)

      968

      Accrued liabilities

      (651)

      1,083

      Income taxes 

      (10,523)

      4,410

      Other liabilities

      -

      115

      Net cash provided by (used in) operating activities

      (18,949)

      2,329




      Investing activities



      Purchases of property and equipment

      (8,408)

      (2,126)

      Payment of notes receivable

      284

      150

      Proceeds from sale of property and equipment

      24

      -

      Notes receivable

      (1,020)

      (696)

      Proceeds from sale of subsidiary

      -

      600

      Net cash used in investing activities

      (9,120)

      (2,072)




      Financing activities



      Proceeds from issuance of shares and warrants

      23,730

      4,351

      Proceeds from issuance of debt, net of loan issuance costs

      63,133

      62

      Payment of lease obligations

      (2,154)

      (2,133)

      Exercise of warrants

      1,365

      -

      Principal repayments of notes payable

      (35,382)

      (35)

      Net cash provided by financing activities

      50,692

      2,245

      Effect of foreign exchange on cash and cash equivalents

      (11)

      184

      Net increase (decrease) in cash and cash equivalents

      22,612

      2,686

      Cash and cash equivalents, beginning of period

      3,392

      2,516

      Cash and cash equivalents, end of period

      $

      26,004

      $

      5,202

      CANSORTIUM INC.




      ADJUSTED EBITDA RECONCILIATION




      USD ('000)

















      Three months ended


      June 30,

      June 30,



      2021

      2020

      Variance

      Net loss

      $

      (25,019)

      $

      (5,467)

      $

      (19,552)

      Interest expense

      4,719

      3,798

      921

      Income taxes

      594

      3,308

      (2,714)

      Depreciation and amortization

      2,429

      2,064

      365

      EBITDA

      $        (17,277)

      $

      3,702

      $

      (20,979)














      Three months ended


      June 30,

      June 30,


      2021

      2020

      Variance

      EBITDA

      $

      (17,277)

      $

      3,702

      $

      (20,979)

      Change in fair value of biological assets

      5,951

      (2,619)

      8,570

      Change in fair market value of derivative

      (1,143)

      (828)

      (315)

      Loss on debt settlement

      10,751

      -

      10,751

      Private placement issuance expense

      6,640

      -

      6,640

      Share-based compensation

      285

      2,362

      (2,077)

      Discontinued operations

      33

      34

      (1)

      Loss on disposal of assets

      1

      $

      (54)

      55

      Other non-recurring expense/(income)

      (18)

      31

      (49)

      Adjusted EBITDA

      $

      5,223

      $

      2,628

      $

      2,595

      SOURCE Cansortium Inc

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.